Filing Details

Accession Number:
0001181431-12-020640
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-30 10:19:59
Reporting Period:
2012-03-29
Filing Date:
2012-03-30
Accepted Time:
2012-03-30 09:19:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1338042 Aegerion Pharmaceuticals Inc. AEGR Pharmaceutical Preparations (2834) 202960116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314575 D Marc Beer C/O Aegerion Pharmaceuticals, Inc.
101 Main Street, Ste 1850
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-29 1,000 $13.74 199,061 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 198,061 Direct
Common Stock 7,156 Indirect by Roth IRA
Common Stock 200 Indirect by son